Effect of zinc and omega-3 supplements as adjuvant therapy in children with attention-deficit hyperactivity disorder
Phase 3
- Conditions
- Attention deficit hyperactivity disorder.Hyperkinetic disorders
- Registration Number
- IRCT201104166201N1
- Lead Sponsor
- Department of Education and Research of Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
1. Age: 6-15 years, 2. Newly diagnosed patient, 3. No history of taking any psychiatric drug, 4. No other psychiatric disorders, 5. There is no contraindication for the use of zinc and omega 3, 6. Diagnosis of ADHD is based on diagnostic criteria in DSM IV and diagnostic interview of psychiatrist. Exclusion criteria: 1. Parents or children withdrew the study because of any reason, 2. Child is suffering from acute physical illness, 3. Children can’t use oral drugs, 4. Complications of drugs is so high that we have to stop them, 5. Alter treatment, 6. The drug is not used, 7. Any previous psychiatric disorders, 8. Mental retardation, 9. The patient can’t use drugs.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Scores in questionnaire. Timepoint: before treatment and then 2 weeks, 4 and 8 weeks after treatment. Method of measurement: 48 questions Conner's Rating Scals questionnaire.
- Secondary Outcome Measures
Name Time Method Adverse reactions. Timepoint: 2 weeks, 4 weeks and 8 weeks after treatment. Method of measurement: drug adverse reactions questionnaire.